Selling pressure pushes Core Scientific stock lower in today's trading

Traders Union
All News
Financial News
Core scientific slides 4.21% today

Highlights

Core Scientific maintains a strong bullish structure, trading above all key moving averages on multiple timeframes.
Momentum indicators are overbought while trend strength is neutral, signaling short-term caution amid a dominant positive bias.
Projected five-session price range is $24.73 to $27.83, with a 75% probability of an upward breakout if buying resumes.

Anton Kharitonov, expert at Traders Union, points out that Core Scientific’s declines and the absence of news fuel uncertainty. He notes momentum indicators show overbought extremes, raising risk of a potential correction. The recent gap down and price closing near session lows suggest sellers are in control. Structure above all moving averages is positive, but the divergence in short-term signals increases downside risks. He warns, "The technicals look stretched and, without fresh news, traders should be wary of a short-term reversal."

Viktoras Karapetjanc, expert at Traders Union, views the price’s position far above its main averages as a strong sign of bullish momentum. He believes the structure remains constructive even after the latest intraday pullback. The elevated readings on key oscillators indicate continued buyer dominance and potential for higher moves. While news is absent, he sees robust chart structure and indicators as evidence the uptrend is intact. He states, "Momentum and technical support levels confirm further growth is likely, so this market still offers bullish setups."

Jainam Mehta, market strategist, notes the divergence between overbought signals and the stock’s continued strength above major averages. He sees potential for sideways consolidation or a tactical pullback toward support. Mehta suggests that a breakout above $27.83 could switch sentiment quickly. He concludes, "If this overbought condition resolves with a shallow dip, I would watch for contrarian long entries near $24.73 support."

Bullish trend persists as overbought signals challenge momentum

Core Scientific remains firmly above its key short-, intermediate-, and long-term moving averages: $26.59 is well above the 20-day ($23.68), 50-day ($20.22), and 200-day ($17.70) Simple Moving Averages. This setup reinforces a strong bullish structure across all timeframes, with the nearest dynamic support around the Ichimoku Kijun level at $23.69, while $27 and the 50-day moving average provide reference points for resistance.

Momentum is moderately positive as the MACD signals a buy and the Average Directional Index (ADX) remains neutral on the daily chart. The Relative Strength Index (RSI) is elevated at 73.89, indicating overbought conditions, which is echoed by the Stochastic RSI, Commodity Channel Index (CCI), and Bull/Bear Power (BBP) forecasts. The BBP reads 3.33, confirming buyers dominate intraday momentum, although this dominance is currently characterized as overbought. The Awesome Oscillator supports the bullish bias. The stock has fallen 4.21% intraday to $26.59, opening with a small downside gap and trading near the session low. Intraday volatility stands at 4.69%, with a tone of sustained selling pressure after the open. Momentum indicators show some divergence with overbought oscillators and neutral ADX contrasting with the overall positive trend signals.

Earlier, analysts noted that Core Scientific was displaying persistent bullish momentum and strong technical positioning despite indications of overbought conditions. The latest session confirms ongoing bullish structure and investor dominance, but with a renewed emphasis on the elevated risk of a sharp correction if price decisively breaches the $24.73 support level in the coming days.

Source of Data: CORZ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.